95 related articles for article (PubMed ID: 21601221)
1. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.
Chen JS; Wang Q; Chen XL; Huang XH; Liang LJ; Lei J; Huang JQ; Li DM; Cheng ZX
J Surg Res; 2012 Jun; 175(2):243-50. PubMed ID: 21601221
[TBL] [Abstract][Full Text] [Related]
2. Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi-institutional propensity-matched cohort study.
Komatsu S; Ueshima K; Kido M; Kuramitsu K; Tsugawa D; Yanagimoto H; Toyama H; Ku Y; Kudo M; Fukumoto T
J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):303-314. PubMed ID: 36047804
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors.
Jiao T; Tang H; Zhang W; Hu B; Wan T; Cao Y; Zhang Z; Wang Y; Cao J; Cui M; Lu S
BMC Surg; 2023 Dec; 23(1):384. PubMed ID: 38114938
[TBL] [Abstract][Full Text] [Related]
4. Preoperative MRI-based multiparametric model for survival prediction in hepatocellular carcinoma patients with portal vein tumor thrombus following hepatectomy.
Zhang L; Zheng T; Wu Y; Wei H; Yang T; Zhu X; Yang J; Chen Y; Wang Y; Qu Y; Chen J; Zhang Y; Jiang H; Song B
Eur J Radiol; 2023 Aug; 165():110895. PubMed ID: 37276744
[TBL] [Abstract][Full Text] [Related]
5. Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance.
Mähringer-Kunz A; Meyer FI; Hahn F; Müller L; Düber C; Pinto Dos Santos D; Galle PR; Weinmann A; Kloeckner R; Schotten S
United European Gastroenterol J; 2021 Jun; 9(5):590-597. PubMed ID: 34077613
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016.
Chan SL; Chong CC; Chan AW; Poon DM; Chok KS
World J Gastroenterol; 2016 Aug; 22(32):7289-300. PubMed ID: 27621575
[TBL] [Abstract][Full Text] [Related]
7. Comparison between laparoscopic liver resection and open liver resection in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
Kim KS; Choi GS; Rhu J; Kim J
Surg Endosc; 2024 Apr; 38(4):2116-2123. PubMed ID: 38438678
[TBL] [Abstract][Full Text] [Related]
8. Ascitic microbiota alteration is associated with portal vein tumor thrombosis occurrence and prognosis in hepatocellular carcinoma.
Guo Y; Tian S; Zhan N; Liu C; Li J; Hu J; Qiu M; Huang B; Dong W
mBio; 2024 May; 15(5):e0024524. PubMed ID: 38564690
[TBL] [Abstract][Full Text] [Related]
9. A Novel Method Using Gadolinium-Ethoxybenzyl Diethylenetriamine Pentaacetate Acid-Enhanced Magnetic Resonance Imaging for Predicting Post-Hepatectomy Liver Failure in Hepatocellular Carcinoma Patients with a Major Portal Vein Tumor Thrombus.
Nishio K; Komatsu S; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; Yanagimoto H; Toyama H; Fukumoto T
Dig Surg; 2024; 41(1):30-36. PubMed ID: 38219712
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcome and risk scoring to predict survival after hepatic resection for hepatocellular carcinoma with portal vein tumor thrombosis.
Kim TS; Yang K; Choi GH; Yang HY; Kim DS; Jo HS; Choi GS; Kim KW; Yoon YC; Han J; Kim DJ; Hwang S; Kang KJ
Ann Hepatobiliary Pancreat Surg; 2024 May; 28(2):134-143. PubMed ID: 38720612
[TBL] [Abstract][Full Text] [Related]
11. Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma.
Tortora R; Farella N; Morisco F; Coppola C; Izzo F; Salomone Megna A; Federico A; Messina V; Nardone G; Piai G; Ragone E; Adinolfi LE; D'Adamo G; Stanzione M; Francica G; Torre P; De Girolamo V; Coppola N; Guarino M; Dallio M; Rocco L; Di Costanzo GG;
Eur J Gastroenterol Hepatol; 2023 Jul; 35(7):734-741. PubMed ID: 37115974
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis.
Ryon EL; Kronenfeld JP; Lee RM; Yopp A; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Russell MC; Goel N; Merchant NB; Datta J
J Surg Oncol; 2021 Feb; 123(2):407-415. PubMed ID: 33125746
[TBL] [Abstract][Full Text] [Related]
13. Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis.
Lim M; Kim J; Rhu J; Choi GS; Joh JW
J Liver Cancer; 2024 Mar; 24(1):102-112. PubMed ID: 38351676
[TBL] [Abstract][Full Text] [Related]
14. Endoportal Radiofrequency Ablation and Stent Placement in Patients with Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma: A Study on Feasibility and Safety.
Mizandari M; Gotsiridze E; Keshavarz P; Nezami N; Azrumelashvili T; Nejati SF; Habib N; Chiang J; Raman SS
J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610893
[No Abstract] [Full Text] [Related]
15. Complete spontaneous necrosis of hepatocellular carcinoma accompanied by portal vein tumor thrombosis: A case report.
Goto Y; Uchino Y; Sasaki S; Shirahama N; Nomura Y; Akiba J; Ishikawa H; Akagi Y; Tanaka H; Okuda K
Int J Surg Case Rep; 2018; 44():220-225. PubMed ID: 29544184
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic scoring system to predict portal vein tumor thrombosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li M; Dang Z; Ma S; Wang Y; Xu X; Li B; Qian P; Dang Z
Am J Transl Res; 2023; 15(7):4600-4609. PubMed ID: 37560212
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment Non-Invasive Biomarkers as Predictors to Estimate Portal Vein Tumor Thrombosis (PVTT) Risk and Long-Term Survival in HBV-Related Hepatocellular Carcinoma Patients Without PVTT.
Liu B; Liu J; Mei X; Zhang ZQ; Fang J; Zhou LL; Zheng JL; Lin HY; Zhu XL; Li DL
J Hepatocell Carcinoma; 2023; 10():2367-2382. PubMed ID: 38164511
[TBL] [Abstract][Full Text] [Related]
18. Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma.
Yoshida R; Koroki K; Makishima H; Ogasawara S; Ishino T; Ogawa K; Nakagawa M; Fujiwara K; Unozawa H; Iwanaga T; Fujita N; Sakuma T; Kanzaki H; Kobayashi K; Kanogawa N; Kiyono S; Nakamura M; Kondo T; Saito T; Nakagawa R; Suzuki E; Ooka Y; Nakamoto S; Tawada A; Chiba T; Arai M; Kaneko T; Wakatsuki M; Kato J; Tsuji H; Kato N
Case Rep Oncol; 2021; 14(2):1103-1110. PubMed ID: 38075390
[TBL] [Abstract][Full Text] [Related]
19. Refining MRI-based criteria for portal vein invasion in hepatocellular carcinoma: improving sensitivity beyond portal vein tumor thrombosis.
Kim J; Jeong WK; Kim JM; Ha SY; Kim K
Abdom Radiol (NY); 2024 Feb; 49(2):437-446. PubMed ID: 37989897
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial.
Lu CD; Jiang YB; Feng JK; Wang L; Wei XB; Zhou B; Lin XL; Guo WX; Lau WY; Cheng SQ
Heliyon; 2023 Sep; 9(9):e20015. PubMed ID: 37810112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
